Hi Ali,
I'm an adult with ITP, but I have often thought about what I would do if my kid had ITP. I have an active 11 year old who would die if he had to restrict his activities, so I can really feel for Dougie's plight. I also have a Ph.D. in biochemistry, although I no longer work in that field and I was not an immunologist, but I can probably shed some insight on the mechanisms by which IVIG and rituximab work.
IVIG is a blood product. It's made by pooling blood donated by many people and extracting antibodies from that blood, specifically, the IGG antibodies. This is then infused into patients. It's not really that clear how it works. One possibility is that some of the antibodies bind to the red blood cells and trick the spleen into destroying them instead of the platelets, but there are probably other mechanisms going on as well.It is, as you said, short term, lasting maybe 4 - 6 weeks. It's a day long infusion and more than one may be required. The side effects are head aches, vomiting and flu-ey feeling after the infusion. Some people also get aseptic meningitis, which is a very severe headache and vomiting. I think the biggest risk is that it is a blood product made from many people. That means that if there's a virus around that can't be tested for, you're at risk, in the same way that haemopheliacs got aids from their treatments in the 80's. That being said I think it's pretty safe at the moment, and probably the safest treatment for ITP. It's just so short lived and inconvenient.
Rituximab is also an antibody, but it's only one antibody that binds to the precursor to the cells that make antibodies, called B-cells. It binds only to this precursor cell, nothing else, and causes this cell to be destroyed. That's why it can take 6 weeks after the last infusion to work; it's not affecting the mature cells, only the immature cells. However, that's clearly not the whole story for ITP patients, because some people show a response to Rituximab immediately. So there's something else going on. If it works, it lasts a lot longer, with remissions lasting about a year. Some people also seem to get longer remissions from it, which make it very attractive. The side effects are again, headache and flu-ey feelings during the transmission and something called serum sickness. The big worry with Rituximab is that it suppresses all your antibodies, and some viruses can be reactivated. Some people have died when a virus called PML, which we all carry, was reactivated, but the numbers are really small. The people who died were all taking steroids or other immunosuppressents which probably didn't help.
So I think Dougie might be right on the mark in choosing Rituximab. If my kid were diagnosed with ITP and bleeding, I'd probably start with IVIG and hope that he was one of the 80% who remit. However, Dougie is clearly not one of those, yet, so rituximab is probably quite a reasonable way to go. It sure would be nice for him to have high counts for a long time.
Hope that helps. Let me know if there's anything I can explain further.
Lily